Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).

MLA

Jayaram, H. N., et al. “Initial Studies on the Mechanism of Action of a New Oncolytic Thiazole Nucleoside, 2-Beta-D-Ribofuranosylthiazole-4-Carboxamide (NSC 286193).” Biochemical Pharmacology, vol. 31, no. 14, July 1982, pp. 2371–80. EBSCOhost, https://doi.org/10.1016/0006-2952(82)90532-9.

APA

Jayaram, H. N., Dion, R. L., Glazer, R. I., Johns, D. G., Robins, R. K., Srivastava, P. C., & Cooney, D. A. (1982). Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193). Biochemical Pharmacology, 31(14), 2371–2380. https://doi.org/10.1016/0006-2952(82)90532-9

Chicago

Jayaram, H N, R L Dion, R I Glazer, D G Johns, R K Robins, P C Srivastava, and D A Cooney. 1982. “Initial Studies on the Mechanism of Action of a New Oncolytic Thiazole Nucleoside, 2-Beta-D-Ribofuranosylthiazole-4-Carboxamide (NSC 286193).” Biochemical Pharmacology 31 (14): 2371–80. doi:10.1016/0006-2952(82)90532-9.